These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7115091)

  • 1. [Experimental study of specific hyposensitization (author's transl)].
    Inazawa M; Nagasawa T; Nakazawa T
    Arerugi; 1982 Mar; 31(3):151-6. PubMed ID: 7115091
    [No Abstract]   [Full Text] [Related]  

  • 2. [Theoretical Basis of Hyposensitization. (author's transl.)].
    Kraft D
    Wien Klin Wochenschr Suppl; 1980; 117():12-4. PubMed ID: 6936975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measurement of specific IgG antibody using protein A-sepharose CL-4B in patients with bronchial asthma undergoing long term hyposensitization therapy (author's transl)].
    Jyo T; Kohmoto K; Kuwabara M; Kodomari Y; Katsutani T; Otsuka T; Tsuboi S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1981 Apr; 19(4):223-9. PubMed ID: 7277908
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant effect of benzalkonium chloride on the allergen-specific IgE, IgG1 and IgG2a antibody formation in BALB/cJ mice.
    Larsen ST; Hansen R; Poulsen OM; Nielsen GD
    Basic Clin Pharmacol Toxicol; 2004 Aug; 95(2):94-6. PubMed ID: 15379788
    [No Abstract]   [Full Text] [Related]  

  • 5. [Theoretical and practical aspects of specific hyposensitization (author's transl)].
    Schöpf E
    Immun Infekt; 1977 Dec; 5(6):219-26. PubMed ID: 338471
    [No Abstract]   [Full Text] [Related]  

  • 6. Engineered recombinant ovomucoid third domain can desensitize Balb/c mice of egg allergy.
    Rupa P; Mine Y
    Allergy; 2006 Jul; 61(7):836-42. PubMed ID: 16792581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of blocking antibodies by RAST interference during pollen desensitization: role of the IgG fraction.
    Chien YK; Anfosso F; Vervloet D; Charpin J
    Biomed Pharmacother; 1982; 36(3):145-9. PubMed ID: 7150707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Induction of Antigen Specific and IgE selective suppression of antibody response (author's transl)].
    Matuhasi T; Usui M
    Rinsho Byori; 1980 Sep; 28(9):831-9. PubMed ID: 6166774
    [No Abstract]   [Full Text] [Related]  

  • 9. Tolerance induced by allergen immunotherapy.
    Plaut M; Rotrosen D
    Clin Allergy Immunol; 2004; 18():681-702. PubMed ID: 15042942
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyposensitization with tyrosine-allergoids (author's transl)].
    Reinert M; Biro G
    Prax Klin Pneumol; 1981 Feb; 35(2):71-5. PubMed ID: 7208409
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of non-protein factor of splenin in the regulation of antibody formation].
    Oliĭnyk BV; Bogdanovych LV; Zhuravskyĭ MH
    Fiziol Zh (1994); 1994; 40(1):100-5. PubMed ID: 7713218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice.
    Huang CF; Wang CC; Wu TC; Wu KG; Lee CC; Peng HJ
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):262-71. PubMed ID: 18376242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models for assessing the effect of toxicants on immunocompetence of mice. III. Augmentation of IgE antibody response to tetanus toxoid by cyclophosphamide in mice.
    Speirs RS; Takenaka T; Benson RW; Jones JM
    J Environ Pathol Toxicol; 1980 Sep; 4(2-3):383-99. PubMed ID: 7462910
    [No Abstract]   [Full Text] [Related]  

  • 14. [Suppressive effect of protein antigen-containing liposomes on IgE antibody in the mouse (author's transl)].
    Nagatomi H; Ogita T; Okudaina H; Miyamoto T; Mizushima Y
    Arerugi; 1981 Dec; 30(12):1099-105. PubMed ID: 7342914
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure-activity relationship of immunostimulatory effects of phthalates.
    Larsen ST; Nielsen GD
    BMC Immunol; 2008 Oct; 9():61. PubMed ID: 18976460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
    Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
    Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergy therapy by intranasal administration with recombinant Lactococcus lactis Producing bovine beta-lactoglobulin.
    Cortes-Perez NG; Ah-Leung S; Bermúdez-Humarán LG; Corthier G; Langella P; Wal JM; Adel-Patient K
    Int Arch Allergy Immunol; 2009; 150(1):25-31. PubMed ID: 19339799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein allergenicity in mice: a potential approach for hazard identification.
    Atherton KT; Dearman RJ; Kimber I
    Ann N Y Acad Sci; 2002 May; 964():163-71. PubMed ID: 12023203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro tests to monitor efficacy of immunotherapy.
    Yunginger JW
    Clin Allergy Immunol; 2004; 18():115-23. PubMed ID: 15042912
    [No Abstract]   [Full Text] [Related]  

  • 20. Peanut-lupine antibody cross-reactivity is not associated to cross-allergenicity in peanut-sensitized mouse strains.
    Lifrani A; Dubarry M; Rautureau M; Aattouri N; Boyaka PN; Tomé D
    Int Immunopharmacol; 2005 Aug; 5(9):1427-35. PubMed ID: 15953569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.